Prevalence of Imaging Biomarkers to Guide the Planning of Acute Stroke Reperfusion Trials | Zendy

Bin Jiang | Zendy; Robyn L. Ball | Zendy; Patrik Michel | Zendy; Tudor Jovin | Zendy; Manisha Desai | Zendy; Ashraf Eskandari | Zendy; Zack Naqvi | Zendy; Max Wintermark | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevalence of Imaging Biomarkers to Guide the Planning of Acute Stroke Reperfusion Trials

Author(s) -

Bin Jiang,

Robyn L. Ball,

Patrik Michel,

Tudor Jovin,

Manisha Desai,

Ashraf Eskandari,

Zack Naqvi,

Max Wintermark

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.117.016759

Subject(s) - medicine , stroke (engine) , acute stroke , clinical trial , intensive care medicine , cardiology , tissue plasminogen activator , mechanical engineering , engineering

Imaging biomarkers are increasingly used as selection criteria for stroke clinical trials. The goal of our study was to determine the prevalence of commonly studied imaging biomarkers in different time windows after acute ischemic stroke onset to better facilitate the design of stroke clinical trials using such biomarkers for patient selection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research